Terra Innovatum Overhauled Board for Commercial Shift
The company appointed three new independent directors to guide its transition toward reactor commercialization.
Updated on Sept. 23, 2026 in People
Live Poll
Do you trust the long-term stability of companies that frequently change their board leadership?
Terra Innovatum has appointed three new independent directors to its board, effective September 22, 2026, as the company pivots from reactor development to commercialization. This leadership change coincides with the resignation of three incumbent board members.
Why it matters
The board restructuring supports the company's move toward bringing its SOLO Micro-Modular Reactor to market. This transition requires shifted oversight as the firm moves from engineering to regulatory and commercial execution.
The company replaced three outgoing directors with three new independent appointees. The firm is currently scaling the engineering behind its 1 MWe micro-reactor, a technology that has been under development for six years.
The players
Terra Innovatum
A nuclear technology company currently transitioning from the development of its SOLO Micro-Modular Reactor to commercial-scale deployment.
Michael Modro
An independent director newly appointed to the board to oversee the company's commercialization strategy.
Kostadin Ivanov
An independent director joining the board to provide technical governance during the reactor's market entry.
Tony Tullio
An independent director tasked with supporting the board through the next phase of corporate growth.
The details
The board changes include the appointment of Michael Modro, Kostadin Ivanov, and Tony Tullio, while Michael W. Howard, Rex S. Jackson, and Peter Hastings stepped down. The company intends to leverage this new board expertise to establish a Technology, Safety and Licensing Committee. This body will provide independent technical input as the firm moves its SOLO technology from the six-year design phase toward commercial rollout.
Timeline
September 22, 2026: New independent directors were appointed.
September 23, 2026: The company formally announced the board changes.
Market Landscape
The transition from prototype to commercialization marks a pivot point for advanced nuclear firms, often necessitating a shift toward directors with deep regulatory and production experience. This change aligns with the industry-wide trend of preparing for final reactor certification.
Operators should monitor the composition of the forthcoming Technology, Safety and Licensing Committee as a signal for the company's regulatory readiness. Watch for further technical disclosures as the company attempts to scale its 1 MWe unit toward a 1 GW maximum output.
The takeaway
Board transitions often signal a move from 'build' to 'sell' phases in high-capital energy sectors. Track the company's upcoming Annual General Meeting for final ratification of these appointments and further details on the committee mandate.
What happens next
The company's new directors will serve until the next Annual General Meeting, where their appointments will be submitted for formal shareholder confirmation.
Further reading
For more on shifts in corporate governance, see our latest coverage on People.
More information
For additional financial and governance disclosures, visit the Terra Innovatum investor relations portal.
Live Poll
Do you trust the long-term stability of companies that frequently change their board leadership?
